Nan Du

938 total citations
27 papers, 713 citations indexed

About

Nan Du is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nan Du has authored 27 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nan Du's work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (6 papers) and Circular RNAs in diseases (5 papers). Nan Du is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (6 papers) and Circular RNAs in diseases (5 papers). Nan Du collaborates with scholars based in China, United States and Japan. Nan Du's co-authors include Xiaojie Xu, Lei Kang, Qinong Ye, Zhongyi Fan, Ying Jiang, Jing Lin, Ziman Zhu, Hanjiang Fu, Huabo Jiao and Lihua Ding and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Biochemical and Biophysical Research Communications.

In The Last Decade

Nan Du

27 papers receiving 706 citations

Peers

Nan Du
Comparison fields: 5 of 79
  • Molecular Biology 438
  • Cancer Research 341
  • Oncology 167
  • Pulmonary and Respiratory Medicine 148
  • Epidemiology 75
Replace Guannan Tang with:
Guannan Tang China
Ken Tajima Japan
Mengxuan Yang China
S. Ménard Canada
Serena Germano Italy
Zhengchuan Niu China
Lingxiong Wang China
Kai Hu China
Zofia F. Bielecka Poland
Guannan Tang China View profile →
Citations per field, relative to Nan Du
Nan Du · 1×
Citations per year, relative to Nan Du
Nan Du · 1×

Countries citing papers authored by Nan Du

Since Specialization
Citations

This map shows the geographic impact of Nan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Du more than expected).

Fields of papers citing papers by Nan Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Du. The network helps show where Nan Du may publish in the future.

Co-authorship network of co-authors of Nan Du

This figure shows the co-authorship network connecting the top 25 collaborators of Nan Du. A scholar is included among the top collaborators of Nan Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Du. Nan Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 21
3 15
4 7
5 10
6 69
7 62
8 16
9 4
10 27
11 39
12 28
13 36
14 24
15 15
16
Sunitinib for patients with locally advanced or distantly metastatic dermatofibrosarcoma protuberans but resistant to imatinib.
34
17
Experimental study of doxorubicin interventional chemotherapy in the treatment of rabbit VX2 renal transplantation carcinoma.
4
18 10
19 225
20 3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026